Post date September 1, 2022 Experience Novo Nordisk $1.1 billion acquisition of Forma Therapeutics We are advising Novo Nordisk on the transaction
Post date January 19, 2022 Experience Smith+Nephew acquisition of Engage Surgical We are advising Smith+Nephew on the transaction
Post date December 21, 2021 Experience Legend Biotech $345 million follow-on offering The shares are listed on the Nasdaq Global Select Market
Post date December 20, 2021 Experience Dynamics Special Purpose $601 million combination with Senti Biosciences We are advising Dynamics, a SPAC, on the transaction
Post date November 19, 2021 Experience Blue Safari Group merger with Bitdeer Technologies We are advising Blue Safari on the transaction
Post date November 19, 2021 Experience Iris Energy $215.3 million IPO The shares are listed on the Nasdaq Global Select Market
Post date November 18, 2021 Experience Marathon Digital Holdings $650 million convertible senior notes offering We advised Marathon Digital Holdings on its offering of 1% convertible notes due 2026
Post date October 26, 2021 Experience IVERIC bio $173.4 million stock offering We advised the underwriters on the SEC-registered equity offering
Post date October 25, 2021 Experience P10 $240 million IPO We advised the underwriters on the IPO and NYSE listing
Post date October 7, 2021 Experience Regions Bank acquires Sabal Capital Partners We are advising Regions on the transaction